Publications by authors named "Angela Jain"

Claim this Profile
Q
Quality-adjusted time without symptoms of disease progression or toxicity of treatment in patients with primary advanced or recurrent endometrial cancer treated with dostarlimab plus carboplatin-paclitaxel versus carboplatin-paclitaxel.
Dana M Chase, Jørn Herrstedt, Eirwen M Miller, Lucy Gilbert, Oleksandr Zub, Angela Jain

Int J Gynecol Cancer· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Population pharmacokinetics and exposure-response relationships of dostarlimab in primary advanced or recurrent endometrial cancer in part 1 of RUBY.
Mita Kuchimanchi, Trine Lembrecht Jørgensen, Eva Hanze, Thierry André, Angela Jain

Br J Clin Pharmacol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NCCN Guidelines® Insights: Ovarian Cancer/Fallopian Tube Cancer/Primary Peritoneal Cancer, Version 3.2024.
Joyce Liu, Andrew Berchuck, Floor J Backes, Joshua Cohen, Rachel Grisham, Angela Jain

J Natl Compr Canc Netw· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Endometrial Cancer Treatment: Long-Term Engagement Strategies.
Krisha J Howell, Angela Jain

Int J Radiat Oncol Biol Phys· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase 1 study of nivolumab in combination with interferon-gamma for patients with advanced solid tumors.
Matthew Zibelman, Alexander W MacFarlane, Kimberly Costello, Thomas McGowan, John O'Neill, Angela Jain

Nat Commun· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NCCN Guidelines® Insights: Ovarian Cancer, Version 3.2022.
Deborah K Armstrong, Ronald D Alvarez, Floor J Backes, Jamie N Bakkum-Gamez, Lisa Barroilhet, Angela Jain

J Natl Compr Canc Netw· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Ovarian Cancer, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology.
Deborah K Armstrong, Ronald D Alvarez, Jamie N Bakkum-Gamez, Lisa Barroilhet, Kian Behbakht, Angela Jain

J Natl Compr Canc Netw· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II Trial of Cabozantinib in Recurrent/Metastatic Endometrial Cancer: A Study of the Princess Margaret, Chicago, and California Consortia (NCI9322/PHL86).
Neesha C Dhani, Hal W Hirte, Lisa Wang, Julia V Burnier, Angela Jain

Clin Cancer Res· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Functional proteomics interrogation of the kinome identifies MRCKA as a therapeutic target in high-grade serous ovarian carcinoma.
Alison M Kurimchak, Carlos Herrera-Montávez, Jennifer Brown, Katherine J Johnson, Valerie Sodi, Angela Jain

Sci Signal· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NCCN Guidelines Insights: Ovarian Cancer, Version 1.2019.
Deborah K Armstrong, Ronald D Alvarez, Jamie N Bakkum-Gamez, Lisa Barroilhet, Kian Behbakht, Angela Jain

J Natl Compr Canc Netw· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
National Cancer Database Report of Lymphadenectomy Trends in Endometrial Cancer.
James Cripe, Elizabeth Handorf, Jennifer Brown, Angela Jain, Stephen Rubin

Int J Gynecol Cancer· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rare epithelial tumors arising in or near the ovary: a review of the risk factors, presentation, and future treatment direction for ovarian clear cell and mucinous carcinoma.
Angela Jain, Michael V Seiden

Am Soc Clin Oncol Educ Book· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metastatic mucinous ovarian cancer and treatment decisions based on histology and molecular markers rather than the primary location.
Angela Jain, Paula D Ryan, Michael V Seiden

J Natl Compr Canc Netw· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis